Latest News and Press Releases
Want to stay updated on the latest news?
-
Announcing the publication of results from SLIM LIVER (also known as A5371) in the Annals of Internal Medicine.
-
ACTG Announces Launch of Clinical Trial Evaluating Combination of Three Novel Immune-based Therapies for HIV Cure
-
ACTG at CROI: HepB-CPG Vaccine Outperforms Standard Hepatitis B Vaccine for HIV Patients with Previous Vaccination Failures
-
ACTG Study Shows Long-Acting Injectable Treatment Effective for Those Struggling with Viral Suppression on Daily Oral Medication
-
ACTG CROI PRESENTATIONS SHOW THAT SEMAGLUTIDE IMPROVES METABOLIC-ASSOCIATED STEATOTIC LIVER DISEASE AMONG PEOPLE LIVING WITH HIV
-
ACTG PRESENTS STUDY AT CROI ELUCIDATING MECHANISM OF CMV ON AGING-RELATED PATHWAYS IN HIV
-
ACTG Announces Launch of Clinical Trial Evaluating Drug-Drug Interaction in Shortened Tuberculosis Regimen Among People Living with HIV
-
Regimen Would Decrease Duration of Treatment from Nine to Six Months LOS ANGELES, Dec. 07, 2023 (GLOBE NEWSWIRE) -- ACTG, a global clinical trials network focused on HIV and other infectious...
-
LOS ANGELES, July 23, 2023 (GLOBE NEWSWIRE) -- The AIDS Clinical Trials Group (ACTG), a global clinical trials network focused on HIV, tuberculosis, hepatitis B and emerging infectious diseases,...
-
LOS ANGELES, March 27, 2023 (GLOBE NEWSWIRE) -- The AIDS Clinical Trials Group (ACTG), the world’s largest HIV research network, today announced the publication of “Varied Patterns of Decay of...